XML 52 R42.htm IDEA: XBRL DOCUMENT v3.4.0.3
Prepaid Expenses and Other Assets (Details) - USD ($)
 3 Months Ended
Mar. 31, 2016
Dec. 31, 2015
Prepaid Expenses and Other Assets [Abstract]    
Prepaid expenses and other assets [1] $ 253,700 $ 183,396
Security deposits 44,200 28,381
Current subtotal 297,900 211,777
Intangible asset (business acquisition) [2] 288,848 0
Accumulated amortization of intangible asset (9,308) 0
Security deposits 0 8,920
Long-term subtotal 279,540 8,920
Total 577,440 $ 220,697
Increase (Decrease) in Prepaid expenses and other assets [1] 70,304  
Increase (Decrease) in Security deposits 15,819  
Increase (Decrease) in Current subtotal 86,123  
Increase (Decrease) in Intangible asset (business acquisition) [2] 288,848  
Increase (Decrease) in Accumulated amortization of intangible asset (9,308)  
Increase (Decrease) in Security deposits (8,920)  
Increase (Decrease) in Long-term subtotal 270,620  
Increase (Decrease) in Prepaid expenses and other assets, Total $ 356,743  
[1] During the first quarter of 2016, we paid $20,500 for an option to purchase additional land nearby to our Portland facility that could be used to construct an 8,000 square foot building should we decide to exercise the option before the end of 2016 for an additional $184,500.
[2] On January 4, 2016, we acquired certain business assets from DAY 1 Technology, LLC of Minnesota. The acquired rights and know-how are primarily related to formulating our bovine antibodies into a gel solution for an oral delivery option to newborn calves via a syringe (or tube). This product format offers customers an alternative delivery option to the bolus (the standard delivery format of the bivalent First Defense product since first approval by the United States Department of Agriculture (USDA) and product launch in 1991) and could allow more market penetration. The formulation was developed for us and has been sold as a feed product without disease claims since 2012. This purchase also includes certain other related private-label products that could generate approximately $300,000 in annual sales. The estimated fair values of the assets purchased in this transaction included inventory of $113,000, machinery and equipment of $132,000 and certain intellectual property intangibles. The total purchase price was approximately $534,000. Approximately $368,000 of this amount was paid as of the closing date, and the remaining balance will be paid contingent upon successful technology transfer and as a royalty on related product sales made through December 31, 2018. The impact of the acquisition on our proforma prior year operations is not significant.